Biognosys Recent Tech Advancements Provide Large Leap Forward for Mass Spec-Based Plasma Proteomics Premium Significant recent improvements in depth of coverage and throughput have substantial implications for both researchers and companies in the space. New Products Posted to GenomeWeb: ASMS Roundup, Bionano Genomics, Parse Biosciences, BioEcho New products and services posted to GenomeWeb for the week of June 5, 2023 Bruker Takes Majority Stake in Proteomics Tech Firm Biognosys With Bruker's investments, Biognosys said that it plans to open a US-based advanced proteomics contract research services lab. New Products Posted to GenomeWeb: Thermo Fisher, Element Biosciences, Dante Genomics, More New products and services posted to GenomeWeb for the week of Dec. 5, 2022. In Brief This Week: Yourgene Health, Bionano Laboratories, Caris Life Sciences, More News items for the week of Sept. 26, 2022. Jul 7, 2022 New Proteomic Technologies Firms Leading With Targeted Analyses Premium Apr 28, 2022 NeoGenomics, Biognosys Partner to Flesh Out Proteomics Offerings for Pharma Market Premium Apr 11, 2022 NeoGenomics, Biognosys Partner on Proteomics for Biopharma Development Mar 15, 2022 Biognosys Strikes Drug Discovery, Development Deal With Kymera Therapeutics Jan 14, 2022 In Brief This Week: BGI, Gencove, Cepheid, Biocartis, Biognosys, Co-Diagnostics, More Nov 15, 2021 Thermo Fisher Scientific, Cellenion Partner to Develop Workflows for Single-Cell Proteomics Analysis Nov 12, 2021 New Products Posted to GenomeWeb: Fluidigm, GenScript, Biognosys, More Oct 26, 2021 Indivumed, Biognosys Expand Partnership to Offer Immunopeptidomics Insights Apr 29, 2021 Plasma Proteomics Prioritizes Throughput but Depth Could Prove a Limitation Premium Apr 13, 2021 Biognosys, Siemens Healthineers Partner for Protein Biomarker Development Mar 18, 2021 Plasma Proteomics Sees Substantial Advances in Depth of Coverage, mod1 Premium Jan 7, 2021 ETH Zurich Team Develops Method for Functional Proteomics Research Premium Sep 3, 2020 Biognosys Positioning Chemoproteomics Tool for Drug Target Discovery, Structural Research Premium May 26, 2020 Thermo Fisher Scientific Inks Pair of Collaborations Around Proteomics Workflows Jan 2, 2020 In 2019, Gains in Throughput Position Proteomics for Future Clinical Impact Premium Dec 2, 2019 Indivumed Partnering With Biognosys to Add Proteomic Data to Cancer Database Oct 17, 2019 Plasma Proteomics Seeing Renewed Interest as Mass Spec Technology Advances Premium Jun 3, 2019 Thermo Fisher Partners with Newomics, Evosep, Biognosys on New Mass Spec Workflows Apr 23, 2019 Roche Partners with Biognosys, Caprion to Demonstrate Proteomics Readiness for Clinical Trials Premium Oct 5, 2018 HUPO Moving in Translational, Clinical Direction as HPP Project Approaches Goal Premium Load More Breaking News Rare Kidney Cancer Genomic Analysis Reveals Potential Target, Suggests Treatment SEC Concludes CareDx Investigation, Recommends No Enforcement Action Streck Quality Controls for DiaSorin's Luminex Sepsis Tests Receive FDA Clearance Adela Closes $48M Financing to Develop Cancer Monitoring, Early Detection Test 3EO Health At-Home Molecular COVID-19 Test Nabs FDA EUA The Scan Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants. Small Study of Gene Editing to Treat Sickle Cell Disease In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms. Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema. Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.